| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004085385A2 Cannabinoid receptor ligands |
| 10/07/2004 | WO2004085358A1 Process for producing tetraalkoxypropane and derivative thereof |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | WO2004084842A2 Inhibitors of cathepsin s |
| 10/07/2004 | WO2004084824A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198823 Process for preparing a creatine heterocyclic acid salt and method of use. |
| 10/07/2004 | US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198724 Contacting a cell with a quinazolinones containing sulfur or its oxides in an amount sufficient to open the potassium channels for the treatment of central or peripheral nervous system disorders |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2519677A1 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 10/07/2004 | CA2519401A1 Cannabinoid receptor ligands |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1169312B1 Glucokinase activators |
| 10/06/2004 | EP1154993B1 Thioamide derivatives |
| 10/06/2004 | CN1535265A Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 10/06/2004 | CN1535163A Delivery system for nucleic acids |
| 10/06/2004 | CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof |
| 10/06/2004 | CN1169796C Catalytic synthesis process of methyl substituted pyrimidyl urea derivative |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169791C Novel acetamide derivatives and protease inhibitors |
| 10/05/2004 | US6800649 Method for inhibiting c-jun expression using JAK-3 inhibitors |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800590 2-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2004082613A2 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines |
| 09/30/2004 | WO2004044046A3 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192913 Process for the racemization of chiral quinazolinones |
| 09/30/2004 | US20040192894 Compositions and methods related to fatty amino acid derivatives |
| 09/30/2004 | US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents |
| 09/30/2004 | US20040192709 7-oxo-pyridopyrimidines (II) |
| 09/30/2004 | US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain |
| 09/30/2004 | US20040192684 Ultraviolet light absorbers |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040191959 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/30/2004 | US20040188673 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/29/2004 | EP1461322A1 Method for the chromatographic isolation of ectoine |
| 09/29/2004 | EP1461083A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1144412B1 Immunosuppressive effects of pteridine derivatives |
| 09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 09/28/2004 | US6797823 Quinoline derivatives and quinazoline derivatives |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797706 Heterocyclecarboxamide derivative |
| 09/23/2004 | WO2004080984A1 Insecticidal phthalamide derivatives |
| 09/23/2004 | WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080979A1 Novel 3-(2-amino-4-pyrimidinyl)-4-hydroxyphenyl ketone derivatives |
| 09/23/2004 | WO2004080977A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 09/23/2004 | WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004056785A3 Uracils having a herbicidal activity |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | US20040186290 transferase enzyme modulators such as 2-(6-Chloropyridin-3-yl)-3-cyclopentyl-N-thiazol-2-ylpropionamide, used for prophylaxis of hyperglycemia and diabetes |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186119 glycogen synthase kinase (GSK-3) inhibitors; for treatment of diabetes and alzheimer's disease |
| 09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 09/23/2004 | US20040186110 Nitrogenous heterocylic compounds |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/23/2004 | DE10311065A1 New 1-(cyclic amino-alkyl)-pyrimidin-2(1H)-one derivatives, are selective dopamine D3 receptor ligands useful for treating CNS disorders, especially schizophrenia or depression |
| 09/23/2004 | DE10310278A1 New N-(benzazinyl)-(hetero)aralkylamine derivatives, are inhibitors of factor Xa and/or related serine proteases, useful e.g. as antithrombotic agents and intermediates |
| 09/22/2004 | EP1460077A1 Novel pyrazolopyrimidones and their use as PDE inhibitors |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1459747A2 Method of inhibiting biosynthesis of Elf5A |
| 09/22/2004 | EP1459745A2 Method of inhibiting biosynthesis of elf5a |
| 09/22/2004 | EP1459744A2 Method of inhibiting biosynthesis of elf5a |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458396A1 4-arylquinazolines and use thereof as nhe-3 inhibitors |
| 09/22/2004 | EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |